rs237917

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The ENST00000472766.1(CAV3):​n.156-6464T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.656 in 151,624 control chromosomes in the GnomAD database, including 33,491 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.66 ( 33491 hom., cov: 32)

Consequence

CAV3
ENST00000472766.1 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.121

Publications

5 publications found
Variant links:
Genes affected
CAV3 (HGNC:1529): (caveolin 3) This gene encodes a caveolin family member, which functions as a component of the caveolae plasma membranes found in most cell types. Caveolin proteins are proposed to be scaffolding proteins for organizing and concentrating certain caveolin-interacting molecules. Mutations identified in this gene lead to interference with protein oligomerization or intra-cellular routing, disrupting caveolae formation and resulting in Limb-Girdle muscular dystrophy type-1C (LGMD-1C), hyperCKemia or rippling muscle disease (RMD). Alternative splicing has been identified for this locus, with inclusion or exclusion of a differentially spliced intron. In addition, transcripts utilize multiple polyA sites and contain two potential translation initiation sites. [provided by RefSeq, Jul 2008]
CAV3 Gene-Disease associations (from GenCC):
  • caveolinopathy
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • autosomal dominant limb-girdle muscular dystrophy type 1C
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • long QT syndrome 9
    Inheritance: AD Classification: MODERATE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
  • rippling muscle disease 2
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
  • distal myopathy, Tateyama type
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • inherited rippling muscle disease
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Brugada syndrome
    Inheritance: AD Classification: LIMITED Submitted by: Genomics England PanelApp
  • hypertrophic cardiomyopathy 1
    Inheritance: AD Classification: LIMITED Submitted by: PanelApp Australia
  • long QT syndrome
    Inheritance: AD Classification: LIMITED Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.98).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.735 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000472766.1. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt

There are no transcript annotations for this variant.

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CAV3
ENST00000472766.1
TSL:2
n.156-6464T>C
intron
N/A

Frequencies

GnomAD3 genomes
AF:
0.656
AC:
99364
AN:
151506
Hom.:
33481
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.572
Gnomad AMI
AF:
0.762
Gnomad AMR
AF:
0.577
Gnomad ASJ
AF:
0.710
Gnomad EAS
AF:
0.315
Gnomad SAS
AF:
0.723
Gnomad FIN
AF:
0.652
Gnomad MID
AF:
0.788
Gnomad NFE
AF:
0.740
Gnomad OTH
AF:
0.686
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.656
AC:
99413
AN:
151624
Hom.:
33491
Cov.:
32
AF XY:
0.649
AC XY:
48106
AN XY:
74086
show subpopulations
African (AFR)
AF:
0.572
AC:
23625
AN:
41274
American (AMR)
AF:
0.577
AC:
8803
AN:
15266
Ashkenazi Jewish (ASJ)
AF:
0.710
AC:
2464
AN:
3468
East Asian (EAS)
AF:
0.314
AC:
1622
AN:
5158
South Asian (SAS)
AF:
0.722
AC:
3473
AN:
4812
European-Finnish (FIN)
AF:
0.652
AC:
6839
AN:
10494
Middle Eastern (MID)
AF:
0.779
AC:
226
AN:
290
European-Non Finnish (NFE)
AF:
0.740
AC:
50228
AN:
67846
Other (OTH)
AF:
0.684
AC:
1443
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1663
3325
4988
6650
8313
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
792
1584
2376
3168
3960
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.619
Hom.:
9720
Bravo
AF:
0.645
Asia WGS
AF:
0.480
AC:
1675
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.98
CADD
Benign
6.4
DANN
Benign
0.51
PhyloP100
0.12

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs237917; hg19: chr3-8812699; API